Contract 75F40122C00148
New York Medical College · Department Of Health And Human Services · September 26, 2022
New York Medical College was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on September 26, 2022 for $2.57 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Silver Spring, MD. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 22, 2025.
Contract details
- PIID
- 75F40122C00148
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Silver Spring, MD
- First action
- September 26, 2022
- Latest action
- September 22, 2025
Description
TO CHARACTERIZE THE CLINICAL PRESENTATION OF C-VAM/TO CONTRAST C-VAM WITH CARDIAC COMPLICATIONS OF INFECTION WITH SARS-COV-2 THAT THE IMMUNIZATION SEEKS TO PREVENT/TO INFORM BEST PRACTICES FOR SURVEILLANCE AND MONITORING FOR C-VAM, INCLUDING IN ASYMP
Modification timeline
-
September 22, 2025Mod P00002 · Other Administrative Action$2.57M
-
August 12, 2025Mod P00001 · Other Administrative Action$2.00M
-
September 26, 2022Base award$2.00M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40122C00148?
Contract 75F40122C00148 is a federal contract awarded to New York Medical College by Department Of Health And Human Services on September 26, 2022 for $2.57 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract 75F40122C00148?
New York Medical College won contract 75F40122C00148 from Department Of Health And Human Services.
How much is contract 75F40122C00148 worth?
Contract 75F40122C00148 has obligated $2.57 million to date.